肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

JCO：Foretinib用于乳头状肾细胞癌疗效显著

2012-12-20 dxy J CLIN ONCOL

Foretinib肾细胞癌乳头状
关注

　　在2012年12月3日在线出版的《临床肿瘤学杂志》(Journal of ClinicalOncology)杂志上，发表了美国国家癌症研究所泌尿肿瘤学部Ramaprasad Srinivasan博士的一项临床II期试验结果，该研究对foretinib用于乳头状肾细胞癌患者的疗效与安全性进行了评价。Foretinib对于晚期乳头状肾细胞癌患者具有活性，并且其毒性可控，对存在胚系MET基因突变的患

肾母细胞癌症

　　在2012年12月3日在线出版的《临床肿瘤学杂志》(Journal of ClinicalOncology)杂志上，发表了美国国家癌症研究所泌尿肿瘤学部Ramaprasad Srinivasan博士的一项临床II期试验结果，该研究对foretinib用于乳头状肾细胞癌患者的疗效与安全性进行了评价。Foretinib对于晚期乳头状肾细胞癌患者具有活性，并且其毒性可控，对存在胚系MET基因突变的患者具有较高的缓解率。业已认为，乳头状肾细胞癌(PRCC)患者的MET基因会出现激活突变或扩增。研究人员最终发现，Foretinib是一种靶点为MET、VEGF、RON、 AXL以及TIE-2受体的多激酶口服抑制剂。该研究得到了葛兰素史克公司的支持。

　　按不同的foretinib剂量安排，研究人员将招募的患者分为两个队列：A组，在每14天中的第1至第5天内每日服用一次foretinib，每次240 mg (间歇给药组)；B组，每日80 mg(每日给药组)。同时按MET通路活化的原理，对患者进行分类(胚系或体细胞MET突变，MET [7q31]扩增，或发生于7号染色体上)。该研究主要终点为总缓解率(ORR)。

　　这项研究共招募了74例患者，每个剂量组37例。按照实体瘤疗效评价标准(RECIST) 1.0版本，患者总缓解率为13.5%，平均无进展存活期为9.3个月，目前尚未获得患者的平均整体存活期。研究人员发现，出现胚系MET基因突变为病情缓解情况的强预测因素(10例患者中有5例患者存在胚系MET基因突变vs 57 例患者中有5例患者不存在胚系MET基因突变)。与foretinib相关的各级最常见不良事件为疲劳、高血压、胃肠道毒性以及非致死性肺栓塞。　

与肾细胞癌相关的拓展阅读：


Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma　　

Purpose 
Foretinib is an oral multikinase inhibitor targeting MET, VEGF, RON, AXL, and TIE-2 receptors. Activating mutations or amplifications in MET have been described in patients with papillary renal cell carcinoma (PRCC). We aimed to evaluate the efficacy and safety of foretinib in patients with PRCC.
Patients And methods 
Patients were enrolled onto the study in two cohorts with different dosing schedules of foretinib: cohort A, 240 mg once per day on days 1 through 5 every 14 days (intermittent arm); cohort B, 80 mg daily (daily dosing arm). Patients were stratified on the basis of MET pathway activation (germline or somatic MET mutation, MET [7q31] amplification, or gain of chromosome 7). The primary end point was overall response rate (ORR).
Results 
Overall, 74 patients were enrolled, with 37 in each dosing cohort. ORR by Response Evaluation Criteria in Solid Tumors (RECIST) 1.0 was 13.5%, median progression-free survival was 9.3 months, and median overall survival was not reached. The presence of a germline MET mutation was highly predictive of a response (five of 10 v five of 57 patients with and without germline MET mutations, respectively). The most frequent adverse events of any grade associated with foretinib were fatigue, hypertension, gastrointestinal toxicities, and nonfatal pulmonary emboli.
Conclusion 
Foretinib demonstrated activity in patients with advanced PRCC with a manageable toxicity profile and a high response rate in patients with germline MET mutations.
    

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2044952, encodeId=c325204495255, content=<a href='/topic/show?id=a4d02358610' target=_blank style='color:#2F92EE;'>#乳头状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23586, encryptionId=a4d02358610, topicName=乳头状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sat Sep 14 10:09:00 CST 2013, time=2013-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978345, encodeId=70ee19e8345e5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Nov 09 03:09:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891032, encodeId=b7cc18910325c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Fri Nov 08 06:09:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913802, encodeId=228c191380279, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Jun 20 15:09:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5306, encodeId=5512530663, content=The truth just siehns through your post, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Tinerci, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5307, encodeId=b507530eec, content=Yo, that's what's up thrtufully., beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Rahul, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=)]
    2013-09-14 jianjun66

    #乳头状#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2044952, encodeId=c325204495255, content=<a href='/topic/show?id=a4d02358610' target=_blank style='color:#2F92EE;'>#乳头状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23586, encryptionId=a4d02358610, topicName=乳头状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sat Sep 14 10:09:00 CST 2013, time=2013-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978345, encodeId=70ee19e8345e5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Nov 09 03:09:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891032, encodeId=b7cc18910325c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Fri Nov 08 06:09:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913802, encodeId=228c191380279, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Jun 20 15:09:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5306, encodeId=5512530663, content=The truth just siehns through your post, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Tinerci, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5307, encodeId=b507530eec, content=Yo, that's what's up thrtufully., beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Rahul, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=)]
    2013-11-09 qingting

    #细胞癌#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2044952, encodeId=c325204495255, content=<a href='/topic/show?id=a4d02358610' target=_blank style='color:#2F92EE;'>#乳头状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23586, encryptionId=a4d02358610, topicName=乳头状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sat Sep 14 10:09:00 CST 2013, time=2013-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978345, encodeId=70ee19e8345e5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Nov 09 03:09:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891032, encodeId=b7cc18910325c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Fri Nov 08 06:09:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913802, encodeId=228c191380279, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Jun 20 15:09:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5306, encodeId=5512530663, content=The truth just siehns through your post, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Tinerci, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5307, encodeId=b507530eec, content=Yo, that's what's up thrtufully., beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Rahul, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=)]
    2013-11-08 lidong40

    #JCO#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2044952, encodeId=c325204495255, content=<a href='/topic/show?id=a4d02358610' target=_blank style='color:#2F92EE;'>#乳头状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23586, encryptionId=a4d02358610, topicName=乳头状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sat Sep 14 10:09:00 CST 2013, time=2013-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978345, encodeId=70ee19e8345e5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Nov 09 03:09:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891032, encodeId=b7cc18910325c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Fri Nov 08 06:09:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913802, encodeId=228c191380279, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Jun 20 15:09:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5306, encodeId=5512530663, content=The truth just siehns through your post, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Tinerci, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5307, encodeId=b507530eec, content=Yo, that's what's up thrtufully., beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Rahul, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=)]
    2013-06-20 ysjykql

    #RET#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2044952, encodeId=c325204495255, content=<a href='/topic/show?id=a4d02358610' target=_blank style='color:#2F92EE;'>#乳头状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23586, encryptionId=a4d02358610, topicName=乳头状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sat Sep 14 10:09:00 CST 2013, time=2013-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978345, encodeId=70ee19e8345e5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Nov 09 03:09:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891032, encodeId=b7cc18910325c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Fri Nov 08 06:09:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913802, encodeId=228c191380279, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Jun 20 15:09:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5306, encodeId=5512530663, content=The truth just siehns through your post, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Tinerci, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5307, encodeId=b507530eec, content=Yo, that's what's up thrtufully., beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Rahul, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=)]
    2013-01-04 Tinerci

    The truth just siehns through your post

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2044952, encodeId=c325204495255, content=<a href='/topic/show?id=a4d02358610' target=_blank style='color:#2F92EE;'>#乳头状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23586, encryptionId=a4d02358610, topicName=乳头状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sat Sep 14 10:09:00 CST 2013, time=2013-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978345, encodeId=70ee19e8345e5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Nov 09 03:09:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891032, encodeId=b7cc18910325c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Fri Nov 08 06:09:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913802, encodeId=228c191380279, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Jun 20 15:09:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5306, encodeId=5512530663, content=The truth just siehns through your post, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Tinerci, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5307, encodeId=b507530eec, content=Yo, that's what's up thrtufully., beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Rahul, createdTime=Fri Jan 04 22:44:00 CST 2013, time=2013-01-04, status=1, ipAttribution=)]
    2013-01-04 Rahul

    Yo, that's what's up thrtufully.

    0